4.7 Article

The relationship between blood pressure and risk of renal cell carcinoma

期刊

INTERNATIONAL JOURNAL OF EPIDEMIOLOGY
卷 51, 期 4, 页码 1317-1327

出版社

OXFORD UNIV PRESS
DOI: 10.1093/ije/dyac042

关键词

RCC; diastolic blood pressure; systolic blood pressure; Mendelian randomization; kidney cancer

资金

  1. Cancer Research UK [C18281/A29019, 14136, C8221/A29017]
  2. Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London
  3. NIHR Imperial Biomedical Research Centre
  4. Danish Cancer Society (Denmark)
  5. Ligue Contre le Cancer
  6. Institut Gustave Roussy
  7. Mutuelle Generale de l'Education Nationale
  8. Institut National de la Sante et de la Recherche Medicale (Inserm) (France)
  9. German Cancer Aid
  10. German Cancer Research Center (DKFZ)
  11. Federal Ministry of Education and Research (BMBF)
  12. Associazione Italiana per la Ricerca sul CancroAIRC-Italy
  13. National Research Council (Italy)
  14. Dutch Ministry of Public Health, Welfare and Sports (VWS), Netherlands Cancer Registry (NKR), LK Research Funds
  15. Dutch Prevention Funds
  16. Dutch ZON (Zorg Onderzoek Nederland)
  17. World Cancer Research Fund
  18. Health Research Fund (FIS)-Instituto de Salud Carlos III (ISCIII)
  19. Swedish Cancer Society
  20. Swedish Research Council
  21. County Councils of Skane
  22. Vasterbotten (Sweden)
  23. Medical Research Council [1000143, MR/M012190/1]

向作者/读者索取更多资源

Diastolic blood pressure (DBP) appears to play an important role in the etiology of renal cell carcinoma (RCC), while the association between systolic blood pressure (SBP) and RCC risk is less clear and seems to be dependent on DBP.
Background The relation between blood pressure and kidney cancer risk is well established but complex and different study designs have reported discrepant findings on the relative importance of diastolic blood pressure (DBP) and systolic blood pressure (SBP). In this study, we sought to describe the temporal relation between diastolic and SBP with renal cell carcinoma (RCC) risk in detail. Methods Our study involved two prospective cohorts: the European Prospective Investigation into Cancer and Nutrition study and UK Biobank, including >700 000 participants and 1692 incident RCC cases. Risk analyses were conducted using flexible parametric survival models for DBP and SBP both separately as well as with mutuality adjustment and then adjustment for extended risk factors. We also carried out univariable and multivariable Mendelian randomization (MR) analyses (DBP: n(instruments) = 251, SBP: n(instruments) = 213) to complement the analyses of measured DBP and SBP. Results In the univariable analysis, we observed clear positive associations with RCC risk for both diastolic and SBP when measured >= 5 years before diagnosis and suggestive evidence for a stronger risk association in the year leading up to diagnosis. In mutually adjusted analysis, the long-term risk association of DBP remained, with a hazard ratio (HR) per standard deviation increment 10 years before diagnosis (HR10y) of 1.20 (95% CI: 1.10-1.30), whereas the association of SBP was attenuated (HR10y: 1.00, 95% CI: 0.91-1.10). In the complementary multivariable MR analysis, we observed an odds ratio for a 1-SD increment (ORsd) of 1.34 (95% CI: 1.08-1.67) for genetically predicted DBP and 0.70 (95% CI: 0.56-0.88) for genetically predicted SBP. Conclusion The results of this observational and MR study are consistent with an important role of DBP in RCC aetiology. The relation between SBP and RCC risk was less clear but does not appear to be independent of DBP.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据